NIAID launch the COVID-19 Prevention Trials Network (COVPN)

On July 8, 2020 the US National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) launched a new clinical trials network to enrol volunteers for large-scale clinical trials testing a variety of investigational vaccines and monoclonal antibodies intended to protect people from COVID-19. Called the COVID-19 Prevention Trials Network (COVPN) it was the merging of 4 existing NIAID-funded clinical trials networks - 3 for AIDS plus the Infectious Diseases Clinical Research Consortium (IDCRC). Within a few weeks they were conducting clincal trial for Moderna's vaccine. The NIAID stated that vaccine generated antibodies will be "different" to antibodies generated from natuaral infection with SARS-CoV-2!!  Antibody tests approved were only those that detected the nucleocapsid, if they targeted "spike antigens" then the immunized person would return a positive result! In 2020 COVPN were conducting clinical trials for: Moderna’s mRNA-1273 vaccine, The COVE Study™ Regeneron’s 10933 and 10987 Antibodies, the REGN-COV2 Study Eli Lilly’s LY3819253 Antibody, the BLAZE-2 Study Pfizer & BioNTech’s BNT162b2 COVID-19 mRNA investigational vaccine The ENSEMBLE Study with Janssen’s Ad26.COV2.S Investigational Vaccine AstraZeneca Investigational COVID-19 vaccines AZD1222

Gates Foundation Dumps mRNA Shares in Q3 of 2021 at Huge Profit

By November 15, 2021 the Bill & Melinda Gates Foundation (BMGF) had sold off 86% of their share holding in BioNTech at massive, untaxable profit. The foundation purchased the shares in September 2019. [1, 2, 3] In November of 2021, Bill Gates, after dumping his stocks, "shockingly declared that “we need a new way of doing the vaccines.”...“We didn’t have vaccines that block transmission,” Gates said, contradicting all of his previous interviews in which he continuously claimed the shots were safe and significantly block transmission." [1]
Gene Therapy
Posted inPublic Health Vaccines

Gene Therapy

The definition of "Gene Therapy" appears to mean different things to different bodies. This page is an attempt to log definitions and understand the evolution of "gene therapy" from the context of how designated "gene therapy" products (i.e. Moderna and…
18 April 2024Posted inPublic Health, Vaccines

US Military-Industrial-Academic technology bio-partnership framework is set

On January 11, 2016 it was announced that "the U.S. Army Contracting Command, Picatinny Arsenal, New Jersey, on behalf of the Joint Project Manager for Medical Countermeasure Systems (JPM-MCS) through the Joint Program Executive Office for Chemical and Biological Defense (JPEO-CBD), announced its intent to enter into a Section 815 Other Transaction (OT) Agreement with the National Chemical and Biological Defense Consortium (NCBDC) for a period of twenty (20) years. " [1] NCBDC "encompasses the expertise, knowledge, technologies, and innovation to meet the program objectives and goals of the coordinated research and development program designed to support the Department of Defense's medical, pharmaceutical, and diagnostic requirements as related to enhancing the mission effectiveness of military personnel." It includes pharma industry, academic institutions, and not-for-profit partners, "forad vanced development efforts to support the Department of Defense’s (DoD) medical, pharmaceutical and diagnostic requirements as related to enhancing the mission effectiveness of military personnel". [1, 4] The NCBDC is an open consortium with a low barrier for membership. Any interested company, academic institution, or contractor can become a member and join the consortium to widen knowledge and technical expertise to continue to advance in technologies and meet Government needs. On April 8, 2016,..> READ MORE

The Real ID Act of 2005 – the prelude to digital ID and vaccine cards

On the back of 9/11, on January 26, 2005 the US government introduce the federal Real ID Act of 2005 (HR 418), which is passed into law later that year "essentially standardized ID requirements for all states" or centralising control! The legislation is implemented by the Department of Homeland Security. [1, 2] By January 2019 it is recognised this centralised/standardised ID system is an international reaching program, with control repercussions for everyone. Making it impossible to work, make a living, travel without their ID! [@1:05:45] Argentina added a "vaccination card" [@52min] to their drivers licence in December 2018, which happened to be the country where Pfizer concentrated their COVID-19 vaccine phase III clinical trial - coincidence? [3]
Vaccination Mandates
Posted inCOVID-19 Vaccines

Vaccine Mandates

A page to capture COVID-19 vaccine "approval" and rollout dates and when vaccine mandates were implemented for as many parts of the world as I can managed to capture...so history does not get forgotten. As vaccine mandates began to faze…
15 December 2023Posted inCOVID-19 Vaccines

FDA pushes EUA regulatory pathway for CV19 jabs and not EAU – bypassing “informed consent” etc.

At the 161st FDA VRPBAC meeting on October 22, 2020 Dr Doran Fink expained why the regulatory pathway for the COVID-19 vaccines should follow the "regulatory standard" of EUA and not EAU. The differences between expanded access use and Emergency Use Authorization are that expanded access use is done -- or is carried out under FDA's investigational new drug regulations. So among many other things, those regulations require use of an institutional review board and also obtaining informed consent from recipients of the investigational vaccine according to regulations for clinical investigations -- research use of investigational vaccines. And so operationally speaking, an expanded access protocol would add some complexity, and that is why Emergency Use Authorization is being considered primarily as the mechanism for addressing the public health emergency that has been declared. Dr Fink, [from pg 203] Dr Fink went on to work for Moderna! "The FDA officials clearly explained here that the reason they went with EUA is specifically NOT to follow any investigational drug rules or cGxP, and NOT to provide informed consent" completely legal while under a declared Public Health Emergency (PHE)! [1] So how did the mRNA products that were not subject to investigational drug..> READ MORE